Literature DB >> 29126250

Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Eugene J Barrett1, Zhenqi Liu1, Mogher Khamaisi2, George L King2, Ronald Klein3, Barbara E K Klein3, Timothy M Hughes4, Suzanne Craft4, Barry I Freedman5, Donald W Bowden5, Aaron I Vinik6, Carolina M Casellini6.   

Abstract

Both type 1 and type 2 diabetes adversely affect the microvasculature in multiple organs. Our understanding of the genesis of this injury and of potential interventions to prevent, limit, or reverse injury/dysfunction is continuously evolving. This statement reviews biochemical/cellular pathways involved in facilitating and abrogating microvascular injury. The statement summarizes the types of injury/dysfunction that occur in the three classical diabetes microvascular target tissues, the eye, the kidney, and the peripheral nervous system; the statement also reviews information on the effects of diabetes and insulin resistance on the microvasculature of skin, brain, adipose tissue, and cardiac and skeletal muscle. Despite extensive and intensive research, it is disappointing that microvascular complications of diabetes continue to compromise the quantity and quality of life for patients with diabetes. Hopefully, by understanding and building on current research findings, we will discover new approaches for prevention and treatment that will be effective for future generations.
Copyright © 2017 Endocrine Society.

Entities:  

Mesh:

Year:  2017        PMID: 29126250      PMCID: PMC5718697          DOI: 10.1210/jc.2017-01922

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  698 in total

Review 1.  The association of chronic kidney disease with brain lesions on MRI or CT: a systematic review.

Authors:  Sanne C M Vogels; Marielle H Emmelot-Vonk; Harald J J Verhaar; Huiberdina Dineke L Koek
Journal:  Maturitas       Date:  2012-02-10       Impact factor: 4.342

Review 2.  Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

Authors:  Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

3.  Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.

Authors:  N Chaturvedi; A K Sjolie; J M Stephenson; H Abrahamian; M Keipes; A Castellarin; Z Rogulja-Pepeonik; J H Fuller
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

Review 4.  Nonenzymatic glycosylation and the pathogenesis of diabetic complications.

Authors:  M Brownlee; H Vlassara; A Cerami
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391

5.  Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha.

Authors:  Katherine A Gallagher; Zhao-Jun Liu; Min Xiao; Haiying Chen; Lee J Goldstein; Donald G Buerk; April Nedeau; Stephen R Thom; Omaida C Velazquez
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

6.  Vitrectomy for proliferative diabetic retinopathy associated with vitreous hemorrhage.

Authors:  R Machemer; G Blankenship
Journal:  Ophthalmology       Date:  1981-07       Impact factor: 12.079

7.  Changes in retinal vessel diameter and incidence and progression of diabetic retinopathy.

Authors:  Ronald Klein; Chelsea E Myers; Kristine E Lee; Ronald Gangnon; Barbara E K Klein
Journal:  Arch Ophthalmol       Date:  2012-06

8.  Acute hyperglycemia-induced endothelial dysfunction in retinal arterioles in cats.

Authors:  Kenji Sogawa; Taiji Nagaoka; Naohiro Izumi; Seigo Nakabayashi; Akitoshi Yoshida
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-30       Impact factor: 4.799

9.  Protein kinase A mediates glucagon-like peptide 1-induced nitric oxide production and muscle microvascular recruitment.

Authors:  Zhenhua Dong; Weidong Chai; Wenhui Wang; Lina Zhao; Zhuo Fu; Wenhong Cao; Zhenqi Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-11-27       Impact factor: 4.310

10.  Association of chronic kidney disease and cerebral small vessel disease with cognitive impairment in elderly patients with type 2 diabetes.

Authors:  Toshitaka Umemura; Takahiko Kawamura; Hiroyuki Umegaki; Naoko Kawano; Shinichi Mashita; Toshimasa Sakakibara; Nigishi Hotta; Gen Sobue
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-07-02
View more
  112 in total

1.  Type 2 diabetes mellitus in the Goto-Kakizaki rat impairs microvascular function and contributes to premature skeletal muscle fatigue.

Authors:  Jefferson C Frisbee; Matthew T Lewis; Jonathan D Kasper; Paul D Chantler; Robert W Wiseman
Journal:  J Appl Physiol (1985)       Date:  2018-12-20

2.  Large Artery Stiffness and New-Onset Diabetes.

Authors:  Julio A Chirinos
Journal:  Circ Res       Date:  2020-12-03       Impact factor: 17.367

3.  Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus: The Role of Protein O-GlcNAc Modification.

Authors:  Yabing Chen; Xinyang Zhao; Hui Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-29       Impact factor: 8.311

4.  Analysis of risk factors for progressive fibrovascular proliferation in proliferative diabetic retinopathy.

Authors:  Yu-Bo Wu; Chen-Guang Wang; Ling-Xian Xu; Chen Chen; Xue-Bin Zhou; Guan-Fang Su
Journal:  Int Ophthalmol       Date:  2020-05-28       Impact factor: 2.031

Review 5.  Exploring the molecular role of endostatin in diabetic neuropathy.

Authors:  Tuhin Mukherjee; Tapan Behl; Aayush Sehgal; Saurabh Bhatia; Harmanpreet Singh; Simona Bungau
Journal:  Mol Biol Rep       Date:  2021-02-09       Impact factor: 2.316

6.  Diabetic microcirculatory disturbances and pathologic erythropoiesis are provoked by deposition of amyloid-forming amylin in red blood cells and capillaries.

Authors:  Nirmal Verma; Miao Liu; Han Ly; Analia Loria; Kenneth S Campbell; Heather Bush; Philip A Kern; Pedro A Jose; Heinrich Taegtmeyer; Donald M Bers; Sanda Despa; Larry B Goldstein; Andrew J Murray; Florin Despa
Journal:  Kidney Int       Date:  2019-09-05       Impact factor: 10.612

7.  Prognostic impact of the ankle-brachial index on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.

Authors:  Claudia R L Cardoso; Juliana V Melo; Guilherme C Salles; Nathalie C Leite; Gil F Salles
Journal:  Diabetologia       Date:  2018-08-15       Impact factor: 10.122

8.  Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI.

Authors:  Kelly G Gwathmey; Reza Sadjadi; William B Horton; Mark R Conaway; Carolina Barnett-Tapia; Vera Bril; James W Russell; Aziz Shaibani; Michelle L Mauermann; Michael K Hehir; Noah Kolb; Jeffrey Guptill; Lisa Hobson-Webb; Karissa Gable; Shruti Raja; Nicholas Silvestri; Gil I Wolfe; A Gordon Smith; Rabia Malik; Rebecca Traub; Amruta Joshi; Matthew P Elliott; Sarah Jones; Ted M Burns
Journal:  Neurology       Date:  2018-05-04       Impact factor: 9.910

9.  Circulating miRNA Profiles Associated With Hyperglycemia in Patients With Type 1 Diabetes.

Authors:  Eiichiro Satake; Marcus G Pezzolesi; Zaipul I Md Dom; Adam M Smiles; Monika A Niewczas; Andrzej S Krolewski
Journal:  Diabetes       Date:  2018-02-16       Impact factor: 9.461

10.  Single-Cell Transcriptome Profiling of the Kidney Glomerulus Identifies Key Cell Types and Reactions to Injury.

Authors:  Jun-Jae Chung; Leonard Goldstein; Ying-Jiun J Chen; Jiyeon Lee; Joshua D Webster; Merone Roose-Girma; Sharad C Paudyal; Zora Modrusan; Anwesha Dey; Andrey S Shaw
Journal:  J Am Soc Nephrol       Date:  2020-07-10       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.